Datametrex Announces Closing Date for Financings

Rhea-AI Summary

Datametrex AI (TSXV:DM / FSE:D4G / OTC:DTMXF) announced it intends to close two financings on November 14, 2025: a non-brokered private placement and a subscription receipt financing.

The company plans to issue up to 50,000,000 common shares at $0.08 for gross proceeds up to $4,000,000, and up to 16,250,000 subscription receipts at $0.08 for gross proceeds up to $1,300,000, totaling up to $5,300,000 in gross proceeds.

Net proceeds are designated for business expansion, a new location, integration of the Yuzu Payment Solution into Datametrex's technology division, and general working capital. The company may pay finder's fees up to 5% cash, 5% shares and 10% warrants or alternatively up to 10% cash and 10% warrants. All securities will be subject to a statutory hold period of four months plus one day.

Positive

• Gross proceeds up to $5.3M
• Up to 50M common shares issued at $0.08 per share
• Proceeds allocated to expansion and Yuzu Payment Solution integration

Negative

• Potential issuance of up to 66,250,000 new securities (shares + subscription receipts) may dilute existing shareholders
• Finder's fees could include up to 10% warrants, increasing future dilution

TORONTO, ONTARIO / ACCESS Newswire / November 11, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce the closing date for both the non-brokered private placement of shares and subscription receipt financing (collectively, the "Offerings"), as previously disclosed in the Company's press release dated September 29, 2025. The Company intends to close both Offerings on November 14, 2025.

Pursuant to the Offerings, the Company intends to issue up to an aggregate of up to 50,000,000 common shares at a price of $0.08 per share for gross proceeds of up to $4,000,000, and up to 16,250,000 subscription receipts (the "Subscription Receipts") at a price of $0.08 per Subscription Receipt, for gross proceeds of up to $1,300,000.

The net proceeds from the Offerings will be used for the Company's existing business expansion, development, new location, the integration of the Yuzu Payment Solution into Datametrex's technology division, and general working capital.

The Company may pay finder's fees of up to 5% cash, 5% shares, and 10% warrants, or up to 10% cash and 10% warrants, in connection with both Offerings, all in accordance with the policies of the TSX Venture Exchange.

All securities issued and issuable pursuant to the Offerings will be subject to a statutory hold period of four months plus one day from the date of issuance, in accordance with applicable Canadian securities laws.

About Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our Company website.

For Additional Information

Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

Forward-Looking Statements

This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.

While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.

Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.

This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.

SOURCE: Datametrex AI Ltd.

View the original press release on ACCESS Newswire

FAQ

When will Datametrex (DTMXF) close the private placement and subscription receipt financings?

Datametrex intends to close both financings on November 14, 2025.

How many shares is Datametrex (DTMXF) offering and at what price?

The company plans to issue up to 50,000,000 common shares at $0.08 per share for up to $4,000,000 gross proceeds.

What are the subscription receipts terms in the Datametrex (DTMXF) financing?

Datametrex will offer up to 16,250,000 subscription receipts at $0.08 each for up to $1,300,000 gross proceeds.

How will Datametrex (DTMXF) use the net proceeds from the financings?

Net proceeds will fund business expansion, a new location, integration of the Yuzu Payment Solution into technology, and general working capital.

Will securities issued in Datametrex's (DTMXF) financings be restricted for resale?

Yes; all securities will be subject to a statutory hold period of four months plus one day under Canadian securities laws.

Will Datametrex (DTMXF) pay finder's fees for the financings and how might that affect shareholders?

The company may pay finder's fees of up to 5% cash, 5% shares and 10% warrants or up to 10% cash and 10% warrants, which could increase dilution to shareholders.